Abstract
Asthma is a respiratory syndrome occurring in individuals who have genetic susceptibility to develop exaggerated airway narrowing to environmental triggers. The symptoms are generally paroxysmal and typically reversible by the use of drugs relaxing airway smooth muscle (ASM). Despite considerable heterogeneity with respect to etiology, age of onset and severity, all affected individuals display some degree of airway hyperresponsiveness (AHR) upon inhalational challenge with spasmogens. ASM is undoubtedly the motor driving airway responsiveness, but whether defects in its contractile properties underlie AHR is still a matter of debate. Many non-muscle changes in asthmatic airways could contribute to AHR. However, this review focuses on the potential contributions of ASM to AHR. Several of the contractile properties of ASM are discussed, including its force-generating capacity, ability to shorten, degree of stiffness, velocity of shortening and ability to relax. The rationale for any of these individual contractile properties being involved in AHR is first explained followed by a brief summary of the current literature concerning their potential contribution to AHR in asthma.
Keywords: Adaptation, breathing, force, relaxation, shortening, stiffness, velocity, signaling, Asthma, respiratory syndrome, airway smooth muscle
Current Respiratory Medicine Reviews
Title: Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?
Volume: 7 Issue: 4
Author(s): Ynuk Bosse and Peter D. Pare
Affiliation:
Keywords: Adaptation, breathing, force, relaxation, shortening, stiffness, velocity, signaling, Asthma, respiratory syndrome, airway smooth muscle
Abstract: Asthma is a respiratory syndrome occurring in individuals who have genetic susceptibility to develop exaggerated airway narrowing to environmental triggers. The symptoms are generally paroxysmal and typically reversible by the use of drugs relaxing airway smooth muscle (ASM). Despite considerable heterogeneity with respect to etiology, age of onset and severity, all affected individuals display some degree of airway hyperresponsiveness (AHR) upon inhalational challenge with spasmogens. ASM is undoubtedly the motor driving airway responsiveness, but whether defects in its contractile properties underlie AHR is still a matter of debate. Many non-muscle changes in asthmatic airways could contribute to AHR. However, this review focuses on the potential contributions of ASM to AHR. Several of the contractile properties of ASM are discussed, including its force-generating capacity, ability to shorten, degree of stiffness, velocity of shortening and ability to relax. The rationale for any of these individual contractile properties being involved in AHR is first explained followed by a brief summary of the current literature concerning their potential contribution to AHR in asthma.
Export Options
About this article
Cite this article as:
Bosse Ynuk and D. Pare Peter, Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?, Current Respiratory Medicine Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339811798281278
DOI https://dx.doi.org/10.2174/157339811798281278 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Zuogui Yin in the Treatment of Male Infertility
Combinatorial Chemistry & High Throughput Screening Inflammaging and Proteases in Abdominal Aortic Aneurysm
Current Vascular Pharmacology Microglial Activation as a Compelling Target for Treating Acute Traumatic Brain Injury
Current Medicinal Chemistry The Use of Mathematical Modelling for Improving the Tissue Engineering of Organs and Stem Cell Therapy
Current Stem Cell Research & Therapy The Role of Eosinophils in Non-Parasitic Infections
Endocrine, Metabolic & Immune Disorders - Drug Targets B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology Therapeutic Targets for Management of Periodontitis and Diabetes
Current Pharmaceutical Design Xolair in Asthma Therapy: An Overview
Inflammation & Allergy - Drug Targets (Discontinued) New Strategies in Drug Development Focusing on the Anti-Protease- Protease Balance in Alpha-1 Antitrypsin Deficiency
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lung Volume Reduction in Patients with COPD: Physiological and Clinical Implications
Current Respiratory Medicine Reviews Recent Progress in Rational Drug Design of Neuraminidase Inhibitors
Current Medicinal Chemistry Allergen-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patent Annotations
Recent Patents on Inflammation & Allergy Drug Discovery Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Immunotherapy in Allergies: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Trafficking Potentials of Unconventional T Cell Subsets
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy
Current Drug Metabolism